Stereotaxis, Inc.

STXSAMEXHealthcare● Active

$1.81

+$0.03(+1.69%)

Market Cap$176903427

P/E Ratio—

52W High$3.59

52W Low$1.7

Avg Volume421K

Open$1.83

Beta1.32

Net Income Financials Revenue

Stereotaxis, Inc. (STXS) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

STXS · net income · updated Jun 9, 2026

Core profitability metrics

STXS · net income · margin · TTM · CAGR

Net income was −$21.6M for FY2025 (fiscal year ending 2025-12-31), up 10.0% year-over-year. Net profit margin was -66.8%. Based on available data, Stereotaxis, Inc. has been profitable since at least 2018.

FY2025 Net Income−$21.6M▲ +10.0% YoY

Trailing 12M (TTM)−$21.7Mtrailing 4 quarters sum

Net Profit Margin-66.8%−$21.6M ÷ $32.4M

YoY Change+10.0%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2018

▸ FMP /income-statement · Annual · STXS net income history · STXS profit margin

Annual net income data

STXS · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$21.6M▲ +10.0%-66.8%$32.4M

FY2024Loss−$24.0M▼ 16.1%-89.3%$26.9M

FY2023Loss−$20.7M▼ 13.2%-77.4%$26.8M

FY2022Loss−$18.3M▼ 70.7%-65.0%$28.1M

FY2021Loss−$10.7M▼ 61.2%-30.6%$35.0M

Net income vs peers (Healthcare)

STXS vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Stereotaxis, Inc.YOU

STXS

−$21.6M+10.0%-66.8%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Stereotaxis, Inc. (STXS) reported net income of −$21.6M for FY2025 (fiscal year ending 2025-12-31), up 10.0% year-over-year. The net profit margin was -66.8% — meaning the company kept $-0.67 of every dollar of revenue as profit.

Based on available data, Stereotaxis, Inc. has been profitable since at least 2018. Net income reached a peak of $116,756 in FY2018. Data available for 15 fiscal years.

Stereotaxis, Inc.'s net profit margin was -66.8% for FY2025, based on the latest annual results.

Investors sometimes search for "Stereotaxis, Inc. net worth" — the company's market capitalization is a separate figure from STXS net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

STXS net income · 4 questions

Stereotaxis, Inc. is not currently profitable on an annual basis. The company reported a net loss of $21.6M for FY2025.

is STXS profitabledoes STXS make a profitSTXS profitabilitySTXS profitable company

▸ Source: FMP /income-statement · GAAP · Stereotaxis, Inc. · Stereotaxis, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026